What Are the RFC1 Disorders?
RFC1 disease, often referred to as CANVAS (Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome), is a group of progressive neurological disorders caused by a genetic change in the RFC1 gene.
The condition affects the systems responsible for coordination, balance, and sensory feedback, leading to difficulties with walking stability and spatial awareness.
Although symptoms typically begin in mid-to-late adulthood, many individuals experience subtle signs for years before diagnosis.
Genotype vs Phenotype
Understanding the difference between genotype and phenotype helps explain why people with RFC1-related disease can have very different symptoms, even when they share the same underlying genetic condition.
What Is a Genotype?
A genotype refers to a person’s genetic makeup — the actual change in the DNA. In RFC1-related disease, the genotype usually involves an abnormal repeat expansion within the RFC1 gene on chromosome 4.
Most commonly, this involves an expanded sequence such as:
AAGGG repeat expansions
Other related repeat motifs in some individuals
A person typically develops disease when they inherit abnormal RFC1 expansions from both parents.
The genotype answers the question: “What genetic change is present?”
What Is a Phenotype?
A phenotype refers to the observable effects of the genetic change — the symptoms, clinical findings, and disease pattern seen in a person. In RFC1-related disease, phenotypes can vary significantly.
Examples may include:
Balance difficulty and gait instability
Sensory neuropathy
Chronic cough
Vestibular dysfunction
Cerebellar ataxia
Swallowing difficulty
Autonomic symptoms
Parkinsonism-like features in some individuals
Different rates of progression
The phenotype answers the question: “How does the disease appear clinically?”
A Simple Analogy
Think of the genotype as:: The genetic “blueprint”
And the phenotype as:: The way the blueprint is expressed in real life
The same underlying genetic change can lead to different clinical pictures in different people.
Why This Matters in RFC1
One of the most important aspects of RFC1-related disease is that the same genotype can produce different phenotypes. Two individuals may carry very similar RFC1 repeat expansions but experience very different symptoms, severity, or progression.
For example:
One person may primarily develop sensory neuropathy
Another may develop classic CANVAS
Another may have chronic cough years before imbalance appears
Some individuals may progress slowly over decades
Others may experience broader neurologic involvement
This variability is one reason RFC1-related disease can be difficult to recognize and diagnose.
Expanding Spectrum of RFC1 Disease
Researchers increasingly recognize RFC1-related disease as a spectrum disorder rather than a single uniform condition.. CANVAS is one important phenotype within that spectrum, but RFC1 expansions may also be associated with other neurologic presentations.
This remains an active area of research.
Genetics of RFC1
The RFC1 gene helps maintain DNA integrity and normal nerve function. In affected individuals, the gene contains an expanded repeating sequence—most commonly the AAGGG repeat—which interferes with normal cellular processes.
This primarily impacts:
The cerebellum (coordination center)
Peripheral sensory nerves
The vestibular system (balance organs of the inner ear)
Inheritance
RFC1 disease is inherited in an autosomal recessive pattern.
This means a person must inherit one altered copy of the gene from each parent to develop the condition.
Carriers usually do not have symptoms.
Diagnosis
Diagnosis involves a combination of clinical evaluation and testing, including:
Neurological examination
Vestibular and balance testing
Nerve conduction studies
Brain imaging
Genetic confirmation of an RFC-1 repeat expansion
Awareness of the condition has increased since its genetic discovery in 2019, but it remains underdiagnosed.
Management
There is currently no disease-modifying therapy, but supportive care can significantly improve function and quality of life.
Management strategies may include:
Physical and balance therapy
Vestibular rehabilitation
Mobility aids when appropriate
Fall-prevention planning
Symptom-targeted treatments
Research aimed at understanding disease mechanisms and developing therapies is ongoing.
Why Ongoing Research Is Important
Understanding why certain RFC1 genotypes lead to different phenotypes may help researchers:
Predict disease progression
Improve diagnosis
Identify subtypes of disease
Develop targeted therapies in the future
Better understand how repeat expansions affect the nervous system
As research advances, the relationship between genotype and phenotype in RFC1-related disease will likely become clearer.